High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention-Reference-Cited by-同舟云学术

High osteopontin levels predict long-term outcome after STEMI and primary percutaneous coronary intervention

Published:2013-04-23 Issue:6 Volume:20 Page:922-929
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Bjerre Mette¹,Pedersen Sune H²,Møgelvang Rasmus³,Lindberg Søren²,Jensen Jan S²⁴,Galatius Søren²,Flyvbjerg Allan¹

Affiliation:

1. The Medical Research Laboratory, Department of Clinical Medicine, Faculty of Health, Aarhus University and Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark

2. Department of Cardiology P, Gentofte University Hospital, Denmark

3. Department of Cardiology, Holbaek University Hospital, Denmark

4. Institute of Surgery and Internal Medicine, Faculty of Health Sciences, University of Copenhagen, Denmark

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2047487313487083

Reference31 articles.

1. Heart Disease and Stroke Statistics—2009 Update

2. Reperfusion strategies in acute ST-segment elevation myocardial infarction

3. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

4. Complement Activation and Cardiovascular Disease

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality;PLOS ONE;2024-05-13

2. Predicting long-term outcomes after primary PCI in Acute ST-segment elevation myocardial infarction patients with single-vessel disease;2024-01-18

3. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)—A Narrative Review;Biomedicines;2023-11-29

4. Association of serum levels of osteopontin and osteoprotegerin with adverse outcomes after endovascular revascularisation in peripheral artery disease;Cardiovascular Diabetology;2022-09-01

5. Clinical and Molecular Implications of Osteopontin in Heart Failure;Current Issues in Molecular Biology;2022-08-11